749.18MMarket Cap-2505P/E (TTM)
3.450High3.330Low41.63KVolume3.340Open3.320Pre Close139.83KTurnover0.03%Turnover RatioLossP/E (Static)224.31MShares10.14052wk High1.53P/B409.18MFloat Cap2.21552wk Low--Dividend TTM122.51MShs Float151.800Historical High--Div YieldTTM3.61%Amplitude2.215Historical Low3.359Avg Price1Lot Size
CureVac Stock Forum
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet